Associations between metabolic and cardiovascular biomarkers and cognition in a nationally representative sample
Adea Rich, Sheina Emrani, Kristen George, Jennifer Manly, Richard Jones, Zachary Kunicki

TL;DR
This study explores how metabolic and cardiovascular biomarkers relate to cognitive performance in older adults using a national sample.
Contribution
The study identifies specific biomarker associations with cognitive domains in a nationally representative sample of older adults.
Findings
Higher cystatin C levels are linked to poorer language fluency and executive function in older adults.
Elevated A1C is associated with reduced executive function performance.
Cystatin C levels differ significantly across cognitive diagnostic groups.
Abstract
Inflammatory, metabolic, and cardiovascular dysregulation contribute to cognitive impairment and Alzheimer’s disease and Alzheimer’s disease and related dementias (AD/ADRD) in older adults. AD/ADRD blood-based biomarkers are a cost-effective and accessible tool for diagnosis and monitoring, and routine blood biomarkers may offer additional insights. However, their associations with high-quality cognitive assessments remain understudied in nationally representative samples. We analyzed 1,335 older adults (mean age: 74.2; 57% female) from the 2016 Health and Retirement Study (HRS) biomarker data and Harmonized Cognitive Assessment Protocol (HCAP). Biomarkers included total cholesterol, high-density lipoprotein, hemoglobin A1C, c-reactive protein, and cystatin C. Cognitive domains (memory, executive function, language fluency) and diagnostic classifications (normal, mild cognitive…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDementia and Cognitive Impairment Research · Alzheimer's disease research and treatments · Neurological Disease Mechanisms and Treatments
